Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein

Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein

Background: Head and neck squamous cell carcinoma (HNSCC) is one most prevalent cancers among worldwide. Aim of this study was to evaluate possible effect of bevacizumab, a vascular endothelial growth (VEGF) factor monoclonal antibody on HNSCC cells in vitro to evaluate angiogenic profile changes. M...

Full description

Bibliographic Details
Main Authors: Hossein Heydar, Kamran Mansouri, Maryam Norooznezhad, Fatemeh Norooznezhad, Abdolreza Mohamadnia, Naghmeh Bahrami
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-04-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Head and neck squamous cell carcinoma
Bevacizumab
Angiogenesis
Vascular endothelial growth
Matrix metalloproteases
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/851

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/851

Similar Items